| Literature DB >> 33023558 |
Takeshi Aoki1, Doaa A Mansour2,3, Tomotake Koizumi2, Kazuhiro Matsuda2, Tomokazu Kusano2, Yusuke Wada2, Tomoki Hakozaki2, Kodai Tomioka2, Takahito Hirai2, Tatsuya Yamazaki2, Makoto Watanabe2, Koji Otsuka2, Ahmed Elewa Abbas Gahin2,4, Masahiko Murakami2.
Abstract
BACKGROUND: Pancreatic fistula is one of the serious complications for patients undergoing distal pancreatectomy, which leads to significant morbidity. The aim of our study is to compare linear stapling closure plus continuous suture with linear stapling closure alone during laparoscopic distal pancreatectomy (LDP) in terms of clinically relevant postoperative pancreatic fistula (POPF) rate.Entities:
Keywords: Continuous suture for stump closure; Laparoscopic distal pancreatectomy; Pancreatic fistula; Peri-firing compression; Stapler closure
Mesh:
Year: 2020 PMID: 33023558 PMCID: PMC7541328 DOI: 10.1186/s12893-020-00876-8
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1Laparoscopic distal pancreatectomy for intraductal papillary mucinous neoplasm. a The tumor was visualized by intraoperative ultrasonography. b The pancreas was mobilized from its inferior border off the retroperitoneum. c Splenic artery was isolated at the superior pancreatic border, and its branches were dissected off the pancreas and clips are applied to secure them. d Splenic vein was isolated from the pancreas, and venous branches were divided and clips were applied for dissection. e Drain was routinely placed close to the stump of pancreas
Fig. 2Transection of pancreas and continuous suture for stump closure, a After mobilization of pancreas and separation of splenic vessels, the parenchyma of pancreas was transected by linear stapler applying peri-firing compression. b, c, d After pancreas transection, continuous suture was added just proximal to the staple line with great care to maintain continuous steady traction throughout the suturing and the regular placement of the suture to achieve equal tension distribution
Patient demographics and pathological diagnosis
| Variables | LSC/CS ( | LSC ( | |
|---|---|---|---|
| Age (years) | 67.3 ± 16.5 | 62.6 ± 16.9 | 0.574 |
| Gender (male/female) | 3/7 | 2/10 | 0.457 |
| BMI (kg/m2) | 22.9 ± 3.2 | 22.8 ± 2.2 | 0.947 |
| ASA score(I/II/III) | 2/7/1 | 3/9/0 | 0.527 |
| Tumor size (mm) | 44.7 ± 26.1 | 40.1 ± 23.3 | 0.691 |
| Pancreatic thickness (mm) | 12.3 ± 3.8 | 11.8 ± 3.9 | 0.716 |
| Pathology | |||
| Intraductal papillary mucinous neoplasm | 5 | 1 | |
| Invasive ductal carcinoma | 2 | 3 | |
| Mucinous cystadenoma | 1 | 2 | |
| Neuroendocrine tumor | 2 | ||
| Serous cystadenoma | 1 | ||
| Hamartoma | 1 | ||
| Solid pseudopapillary neoplasm | 1 | ||
| Others | 2 | 1 | |
LSC/CS Linear stapling closure plus continuous suture, LSC Linear stapling closure
Values are presented as mean ± SD
Surgical outcomes and complications (pancreatic stump closure)
| Variables | LSC/CS (n = 10) | LSC (n = 12) | |
|---|---|---|---|
| Operative time (min) | 187.0 ± 51.4 | 188.3 ± 55.6 | 0.947 |
| Blood loss(g) | 240.4 ± 220.2 | 135.0 ± 142.9 | 0.443 |
| Postoperative hospital stay (days) | 11.9 ± 2.9 | 19.9 ± 11.7 | 0.037 |
| Postoperative complication(%)≧C-D Grade IIIa (%) | 0 (0) | 4 (33.3) | 0.043 |
| Pancreatic fistula(%)≧ Grade Bb (%) | 0 (0) | 4 (33.3) | 0.043 |
| 30-day mortality | 0 | 0 | – |
LSC/CS Linear stapling closure plus continuous suture, LSC Linear stapling closure
Values are presented as mean ± SD
aClavien-Dindo Classification
bInternational Study Group of Pancreatic Fistula (ISGPF) classification
Surgical outcomes and complications (spleen preserving laparoscopic distal pancreatectomy)
| Variables | splenectomy ( | spleen-preserving ( | |
|---|---|---|---|
| Operative time (min) | 180.9 ± 57.0 | 211.0 ± 23.8 | 0.306 |
| Blood loss(g) | 170.1 ± 181.3 | 226.0 ± 213.8 | 0.476 |
| Postoperative hospital stay (days) | 14.5 ± 7.1 | 22.2 ± 15.0 | 0.157 |
| Postoperative complication(%)≧C-D Grade IIIa (%) | 2 (11.8) | 2 (40.0) | 0.150 |
| Pancreatic fistula(%)≧ Grade Bb (%) | 2 (11.8) | 2 (40.0) | 0.150 |
| 30-day mortality | 0 | 0 | – |
Values are presented as mean ± SD
aClavien-Dindo Classification
bInternational Study Group of Pancreatic Fistula (ISGPF) classification